A drug intended for therapy of congenital $\alpha$₁-antitrypsin deficiency is

Question

Quizplus · Accepted Answer

$\alpha$₁-proteinase inhibitor (API)is indicated for long-term replacement therapy in individuals with congenital deficiency of API,with clinically demonstrable panacinar emphysema.At the present time,three agents are available: Aralast,Prolastin,and Zemaira.Aralast and Zemaira are indicated only for patients who have established F1F1F1S1?F1F1F10₁-proteinase deficiency.Pulmozyme (dornase alfa)is a mucolytic,Pneumovax is a vaccine,and prednisone is a steroid.Although these drugs may be helpful at some point in the disease process,they do not specifically treat F1F1F1S1?F1F1F10₁-antitrypsin deficiency.

A Drug Intended for Therapy of Congenital α\alphaα 1-Antitrypsin Deficiency Is A)pulmozyme

A Drug Intended for Therapy of Congenital $\alpha$ ₁-Antitrypsin Deficiency Is
A)pulmozyme